We are live on
!
Find out more
Biogen
BIIB
BIIB
874 hedge funds and large institutions have $20.2B invested in Biogen in 2024 Q4 according to their latest regulatory filings, with 131 funds opening new positions, 300 increasing their positions, 322 reducing their positions, and 159 closing their positions.
New
Increased
Maintained
Reduced
Closed
1.72% more ownership
Funds ownership: 89.11% → 90.83% (+1.7%)
7% less repeat investments, than reductions
Existing positions increased: 300 | Existing positions reduced: 322
5% less funds holding
Funds holding: 916 → 874 (-42)
13% less call options, than puts
Call options by funds: $310M | Put options by funds: $356M
18% less first-time investments, than exits
New positions opened: 131 | Existing positions closed: 159
19% less capital invested
Capital invested by funds: $25.1B → $20.2B (-$4.84B)
38% less funds holding in top 10
Funds holding in top 10: 8 → 5 (-3)
Holders
874
Holders Change
-42
Holders Change %
-4.59%
% of All Funds
11.51%
Holding in Top 10
5
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-37.5%
% of All Funds
0.07%
New
131
Increased
300
Reduced
322
Closed
159
Calls
$310M
Puts
$356M
Net Calls
-$45.6M
Net Calls Change
+$21.7M
Top Buyers
| 1 |
Pacer Advisors
Malvern,
Pennsylvania
|
+$447M |
| 2 |
D.E. Shaw & Co
New York
|
+$198M |
| 3 |
VanEck Associates
New York
|
+$163M |
| 4 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$125M |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$91.9M |
Top Sellers
| 1 |
JP Morgan Chase
New York
|
-$533M |
| 2 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$230M |
| 3 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
-$195M |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
-$170M |
| 5 |
ClearBridge Investments
New York
|
-$101M |
